Showing results (111-120 of 9,659) with videos related to
Sort By:
Pageof 966
Leukemia|August 30, 2002
Clinical activity of arsenic trioxide for the treatment of multiple myelomaN C Munshi, G Tricot, R Desikan, et al.Leukemia|July 18, 2001
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimenR V Smalley, E Weller, M J Hawkins, et al.Leukemia|October 30, 2001
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblastsT Wieder, A Prokop, B Bagci, et al.Leukemia|October 30, 2001
Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cellsA K Boer, A L Drayer, E VellengaLeukemia|October 30, 2001
Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtypeM Bernard, R Gressin, F Lefrère, et al.Leukemia|May 1, 1992
Amplification and sequencing of genomic breakpoints located within the M-bcr region by Vectorette-mediated polymerase chain reactionK I Mills, A M Sproul, D Ogilvie, et al.Leukemia|January 17, 2003
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemiaJ-M Luo, H Yoshida, S Komura, et al.Leukemia|January 17, 2003
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcomeN Feller, G J Schuurhuis, M A van der Pol, et al.Leukemia|January 17, 2003
Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemiaC H Seedhouse, E P Das-Gupta, N H RussellLeukemia|January 17, 2003
Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cellsT Netelenbos, J van den Born, F L Kessler, et al.Pageof 966